Washington, D.C. – As veterans advocate and Washington state’s Republican U.S. Senate candidate Tiffany Smiley has been saying: In Joe Biden’s America, “it’s easier for a child to find fentanyl than it is for a mother to find baby formula.”
With the Biden administration admitting the baby formula crisis is still unsolved, the Washington Free Beacon uncovers that after thirty-year incumbent Democrat Patty Murray blamed manufacturers for the shortage, she took their money and went silent
Smiley campaign spokeswoman Elisa Carlson puts it best: “This is a classic Washington, D.C. move: complaining about a problem, lining your pockets from the source of the problem, and then doing nothing. After 30 years in the Senate, Patty Murray has become Washington, D.C.”
Read more below:
Washington Free Beacon: “Patty Murray Blamed Manufacturers for Baby Formula Shortage. Then Their Lobbyists Donated to Her Campaign.”
Sen. Patty Murray (D., Wash.) was hammering baby formula manufacturers to help alleviate a nationwide shortage until August. That just so happens to be when the chief lobbyist for the industry’s trade group nearly maxed out donations to her campaign.
Murray, who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, in May urged the Infant Nutrition Council of America to “take immediate action” to end the “unacceptable burden” the crisis was placing on American families. Three months later, Murray’s campaign accepted $2,750 from the trade group’s lobbyist. Lobbyists representing Abbott Laboratories, the largest member of the trade group, also contributed to Murray’s campaign. Lori Denham, a partner at Kountoupes, Denham, Carr, and Reid in June donated $1,000 to the campaign. Lisa Kountoupes, another partner at the firm, donated $1,500 this year to the senator. Jessica Schulken, a principal at the Russell Group in July contributed $1,500 to Murray.
The veteran Democratic senator has since fallen silent on the issue. She successfully removed provisions meant to address the baby formula shortage from a September FDA reauthorization bill, according to Roll Call …
Murray’s office did not respond to a request for comment.
Read the full story here.
###
